ATM mutations in Finnish breast cancer patients

[1] ATR/ATM-mediated phosphorylation of human Rad17 is required for genotoxic stress responses [J]. NATURE, 2001, 411 (6840) : 969 - 974

[2] Mutations of the ATM gene detected in Japanese ataxia-telangiectasia patients: possible preponderance of the two founder mutations 4612del165 and 7883del5 [J]. HUMAN GENETICS, 1998, 102 (04) : 403 - 408

[3] Cancer risk in ATM heterozygotes: A model of phenotypic and mechanistic differences between missense and truncating mutations [J]. MOLECULAR GENETICS AND METABOLISM, 1999, 68 (04) : 419 - 423

[4] Predominance of null mutations in ataxia-telangiectasia [J]. HUMAN MOLECULAR GENETICS, 1996, 5 (04) : 433 - 439

[5] Evidence of founder mutations in Finnish BRCA1 and BRCA2 families [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (06) : 1544 - 1548

[6] Rapid and efficient ATM mutation detection by fluorescent chemical cleavage of mismatch:: identification of four novel mutations [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 1999, 7 (03) : 310 - 320

[7] Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (17) : 9603 - 9608

[8] Identical mutation in 55% of the ATM alleles in 11 Norwegian AT families:: evidence for a founder effect [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 (03) : 235 - 244

[9] Laake K, 2000, HUM MUTAT, V16, P232, DOI 10.1002/1098-1004(200009)16:3<232::AID-HUMU6>3.0.CO

[10] 2-L

[1] ATR/ATM-mediated phosphorylation of human Rad17 is required for genotoxic stress responses [J]. NATURE, 2001, 411 (6840) : 969 - 974

[2] Mutations of the ATM gene detected in Japanese ataxia-telangiectasia patients: possible preponderance of the two founder mutations 4612del165 and 7883del5 [J]. HUMAN GENETICS, 1998, 102 (04) : 403 - 408

[3] Cancer risk in ATM heterozygotes: A model of phenotypic and mechanistic differences between missense and truncating mutations [J]. MOLECULAR GENETICS AND METABOLISM, 1999, 68 (04) : 419 - 423

[4] Predominance of null mutations in ataxia-telangiectasia [J]. HUMAN MOLECULAR GENETICS, 1996, 5 (04) : 433 - 439

[5] Evidence of founder mutations in Finnish BRCA1 and BRCA2 families [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (06) : 1544 - 1548

[6] Rapid and efficient ATM mutation detection by fluorescent chemical cleavage of mismatch:: identification of four novel mutations [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 1999, 7 (03) : 310 - 320

[7] Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (17) : 9603 - 9608

[8] Identical mutation in 55% of the ATM alleles in 11 Norwegian AT families:: evidence for a founder effect [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 (03) : 235 - 244

[9] Laake K, 2000, HUM MUTAT, V16, P232, DOI 10.1002/1098-1004(200009)16:3<232::AID-HUMU6>3.0.CO

[10] 2-L